FIL Ltd has filed 24 insider transactions across 2 companies since February 2023.
Most recent transaction: a transaction of 54092 shares of Bicara Therapeutics Inc. ($BCAX) on September 16, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Common Stock | 54092 | $0.00 | 54,092.0000 | 580,109,000 | 9999.99% | 0.01% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Common Stock | 606885 | $0.00 | 660,977.0000 | 580,109,000 | 1121.95% | 0.10% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Common Stock | 352876 | $0.00 | 1,013,853.0000 | 580,109,000 | 53.39% | 0.06% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Series Seed Preferred Stock | 54092 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.01% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Series B Preferred Stock | 606885 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.10% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | FIL Ltd | Not found | C | Series C Preferred Stock | 352876 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 0.06% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 4013678 | $0.00 | 5,221,153.0000 | 9,584,000 | 332.40% | 41.88% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 620499 | $0.00 | 5,841,652.0000 | 9,584,000 | 11.88% | 6.47% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 452867 | $0.00 | 6,294,519.0000 | 9,584,000 | 7.75% | 4.73% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 179242 | $0.00 | 6,473,761.0000 | 9,584,000 | 2.85% | 1.87% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 71636 | $0.00 | 6,456,196.0000 | 9,584,000 | 1.12% | 0.75% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 10154 | $0.00 | 6,466,350.0000 | 9,584,000 | 0.16% | 0.11% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 7411 | $0.00 | 6,473,761.0000 | 9,584,000 | 0.11% | 0.08% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 494035 | $0.00 | 6,473,761.0000 | 9,584,000 | 8.26% | 5.15% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Ordinary Shares | 624239 | $0.00 | 6,473,761.0000 | 9,584,000 | 10.67% | 6.51% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series A Convertible Preferred Shares | 4013678 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 41.88% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series A+ Convertible Preferred Shares | 620499 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 6.47% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series B Convertible Preferred Shares | 452867 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 4.73% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series B-1 Convertible Preferred Shares | 179242 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 1.87% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series A Convertible Preferred Shares | 71636 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 0.75% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series A+ Convertible Preferred Shares | 10154 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 0.11% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series B Convertible Preferred Shares | 7411 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 0.08% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series B-1 Convertible Preferred Shares | 494035 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 5.15% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | FIL Ltd | Other | C | Series A Convertible Preferred Shares | 624239 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 6.51% |